Abstract:Objective To discuss the selection of surgical procedure for early hepatocellular carcinoma (HCC) patients by comparing the efficacy of liver resection and transplantation and analyzing the independent risk factors of patients' survival. Methods Clinical data of 53 HCC patients received hepatic resection or liver transplantation in the First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University from January 2002 to December 2009 were analyzed retrospectively. The patients were pathologically confirmed as HCC and met with the Milan criteria. The patients were divided into the liver resection group and liver transplantation group. There were 31 cases in the liver resection group (22 males and 9 females) with the age of (54±10) years old. There were 22 cases in the transplantation group (19 males and 3 females) with the age of (49±9) years old. The informed consents of all patients were obtained and the ethical committee approval was received. The general clinical data of the patients were compared by t test, rank sum test, and chi-square test. And the prognosis analysis of patients in the 2 groups were conducted using Cox multiple regression model. Results There were no significant differences in the patients' age, gender, positive rate of hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody, alpha-fetoprotein (AFP), Child-Pugh grading, tumor numbers, size, liver capsule infiltration and tumor Edmonson grading between 2 groups (all in P>0.05). All the patients were followed up for 6-91 months with an average of 35 months. The 1-, 2-, 3-year cumulative survival rates were 87%, 80%, 71% in the liver resection group and were 86%, 77%, 68% in the liver transplantation group respectively. There was no significant difference in the cumulative survival rate beween 2 groups (χ2=0.739, P>0.05). The 1-, 2-, 3-year disease free survival rates were 84%, 77%, 74% in the liver resection group and were 77%, 68%, 59% in the liver transplantation group. There was no significant difference in the disease free survival rate between 2 groups (χ2=0.826, P>0.05). For the Child-Pugh grade A patients, no significant differences were observed in the comparison of cumulative survival rates and disease free survival rates between 2 groups (χ2=2.562, 2.676; P>0.05) , which was the same as the grade B patients (χ2=0.006, 0.012; P>0.05) . The surgical procedure and tumor Edmonson grading were significantly related with the patients' prognosis (RR=0.291, 5.878; P=0.025, 0.020) . The patients who received liver resection and with high degree of tumor differentiation had better prognosis. Conclusions For the HCC patients within Milan Criteria and with liver function of Child-Pugh grade A or B, liver resection should be the preferred treatment. The patients' prognosis after the operation is related with tumor differentiation. The patients with high degree of tumor differentiation have better prognosis. Key words: Carcinoma, hepatocellular; Liver transplantation; Hepatectomy

How Admissions to Various Medical Specialty Divisions Determines the Outcome of Patients with Hepatocellular Carcinoma: Results from a Retrospective Study in a Large Hospital of Northwest China

Hepatocellular Carcinoma in a Large Medical Center of China over a 10-Year Period: Evolving Therapeutic Option and Improving Survival.

Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons.

Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy

Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study.

Surgical Treatment of Primary Hepatoeellular Carcinoma: a 20-Year Clinical Experience in 7566 Patients

Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias

Comparison of Four Staging Systems in Predicting Outcomes and Guiding Option of Treatment for Patients with Hepatocellular Carcinoma

Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study

Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma

Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.

Surgical Resection Improves Long-Term Survival of Patients with Hepatocellular Carcinoma Across Different Barcelona Clinic Liver Cancer Stages.

Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China

Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma

Survival In Liver Transplant Recipients With Hepatitis B- Or Hepatitis C-Associated Hepatocellular Carcinoma: The Chinese Experience From 1999 To 2010

Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study

Selection of Surgical Procedure in the Treatment of Early Hepatocellular Carcinoma

Tumor stage and primary treatment selection among patients with hepatocellular carcinoma from 2003 to 2013

HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival

Clinical and Pathological Analysis of 27 Patients with Combined Hepatocellular-Cholangiocarcinoma in an Asian Center

Impact of Traditional Chinese Medicine on Prognosis of Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study